← Eichor
Study identifier: NCT06850545 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

Condition: Metastatic Prostate Adenocarcinoma · PSMA PET-Positive Castration-Resistant Prostate Cancer  ·  Sponsor: Kuopio University Hospital

PhaseN/A
Planned participants150
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

KuPSMALu-trial is an observational study for patients treated with 177LuPSMA-I\&T in Kuopio University Hospital, Finland. Study focuses on efficacy, safety and biomarker research.

This description comes directly from the study's public registry record.

Talk to the study team

Okko-Sakari Kääriäinen, MD  ·  +358447179433  ·  okko.kaariainen@pshyvinvointialue.fi

Always discuss trial participation with your own doctor first.

Locations (1)

Kuopio University HospitalKuopio, Northern Savonia, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06850545